B-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it ...
B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most ...
Azercabtagene zapreleucel has been granted fast track designation from the FDA for the treatment of diffuse large B-cell ...
Wojciech Jurczak, MD, PhD, ​​discusses the future of B-cell lymphoma therapy, with a focus on Bruton's tyrosine kinase ...
The Brighterside of News on MSN8h
Groundbreaking sugar treatment could be the cure for baldnessIf you're among the millions experiencing thinning hair, new research into a naturally occurring sugar could offer fresh hope ...
FDA grants fast track designation to azer-cel, an allogeneic CAR T-cell therapy, for relapsed or refractory diffuse large ...
Specific vitamins and nutrients can help boost the hair growth cycle and support optimum growth. However, vitamin ...
Chugai Pharmaceutical has launched Lunsumio (mosunetuzumab) in Japan for patients with relapsed or refractory follicular ...
Chugai introduces Lunsumio for intravenous infusion, a bispecific antibody to treat relapsed or refractory follicular lymphoma in Japan: Tokyo Thursday, March 20, 2025, 11:00 Hrs ...
AstraZeneca has recently been investing heavily in the cell therapy space, including two acquisitions for TeneoTwo and ...
Struggling with brittle hair? Discover six nutrient-rich foods proven to strengthen strands, boost your hair growth and end ...
The EC approved the CAR T-cell therapy based on data from a Phase II study showing a 94 percent complete response rate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback